Copertina

Differential peripheral memory T cell subsets sensitively indicate the severity of nonalcoholic fatty liver disease

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Akira Kado, Takeya Tsutsumi, Hiroshi Yotsuyanagi, Kazuhiko Ikeuchi, Kazuya Okushin, Kyoji Moriya, Kazuhiko Koike, Mitsuhiro Fujishiro
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Hepatology Research
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Real‐world trends in acute viral hepatitis in Japan: A nationwide questionnaire‐based survey
di: Kazuya Okushin, et al.
Pubblicazione: (2024)

Toward a Synthetic Data Revolution: Diffusion Model‐Enhanced Hepatocellular Carcinoma Prediction in Steatotic Liver Disease
di: Masaya Sato, et al.
Pubblicazione: (2026)

Helicobacter pylori and metabolic syndrome‐related adipokines in nonalcoholic fatty liver disease pathophysiology
di: J Kountouras, et al.
Pubblicazione: (2024)

Integrated policy of medical expense subsidies and clinical registry for patients with liver cancer and decompensated cirrhosis in Japan
di: Yasue Takeuchi, et al.
Pubblicazione: (2024)

Refining the predictive utility of aspartate aminotransferase to platelet ratio index in nonalcoholic fatty liver disease patients with COVID‐19
di: Kengo Matsumoto, et al.
Pubblicazione: (2024)

Mendelian‐randomization study revealed causal relationship between nonalcoholic fatty liver disease and osteoporosis/fractures
di: Xiong Pei, et al.
Pubblicazione: (2024)

Response to “Letter to the Editor: Pre‐Treatment Liver Stiffness is a Stronger Predictor of Hepatocellular Carcinoma Development Than Post‐Treatment Liver Stiffness After Hepatitis C Virus Eradication”
di: Takuma Nakatsuka, et al.
Pubblicazione: (2025)

Impact of metabolic dysfunction‐associated fatty liver disease on the incidence of Helicobacter pylori‐negative gastric cancer
di: Tomoyuki Nakane, et al.
Pubblicazione: (2024)

Prediction of intrahepatic covalently closed circular DNA levels in patients with resolved hepatitis B virus infection: Impact of serum antibody to hepatitis B core antigen titers
di: Sung Kwan Bae, et al.
Pubblicazione: (2024)

Selective Testing Recommendation Considering Clinical Timelines Improve Opportunities for Hepatitis C Diagnosis
di: Kazuya Okushin, et al.
Pubblicazione: (2026)

High Intrahepatic cccDNA in Resolved HBV Infection: Insights From Living Donor Liver Transplantation With Anti‐HBc‐Positive Grafts
di: Sung Kwan Bae, et al.
Pubblicazione: (2026)

The incidence of nonampullary duodenal cancer in Japan 2016–2020: analysis of a national cancer registry
di: Naomi Kakushima, et al.
Pubblicazione: (2024)

Grip strength is a strong indicator of osteoporosis in both women and men with chronic liver disease
di: Tatsuki Ichikawa, et al.
Pubblicazione: (2025)

Cachexia in Cirrhosis Is Characterized by Sex‐Specific Loss of Muscle Mass and Adipose Tissue
di: Takao Miwa, et al.
Pubblicazione: (2025)

Association of metabolic dysfunction‐associated fatty liver disease with gallstone development: A longitudinal study
di: Masahiro Sogabe, et al.
Pubblicazione: (2024)

Editorial for “A new imaging classification for safer radial access visceral intervention of the liver and optimal case selection: A preliminary report”
di: Akira Yamada
Pubblicazione: (2024)

Cachexia and Type 2 Diabetes Mellitus Are Independent Factors for Mortality in Patients With Cirrhosis
di: Takao Miwa, et al.
Pubblicazione: (2025)

Cachexia is an independent predictor of mortality in patients with cirrhosis
di: Takao Miwa, et al.
Pubblicazione: (2025)

Brief intervention for chronic liver disease patients with alcohol use disorder in a hepatology outpatient unit: Effects and limitations
di: Nagisa Hara, et al.
Pubblicazione: (2024)

Metabolic fatty liver syndromes: where do we stand in 2024?
di: Wah‐Kheong Chan, et al.
Pubblicazione: (2024)

Fatty liver index and somatic composition in subjects receiving medical health checkup
di: Kosuke Ushiro, et al.
Pubblicazione: (2024)

LIVERSTAT for risk stratification for patients with metabolic dysfunction‐associated fatty liver disease
di: Yong Wen Leow, et al.
Pubblicazione: (2024)

Validation of serum non‐invasive tests of liver fibrosis as prognostic markers of clinical outcomes in people with fatty liver disease in Australia
di: Karl Vaz, et al.
Pubblicazione: (2024)

Changes in serum myostatin levels among patients with type C liver cirrhosis treated with direct‐acting antivirals
di: Tomoyuki Suehiro, et al.
Pubblicazione: (2025)

Exploratory prospective, randomized phase II study of neoadjuvant transcatheter arterial chemoembolization plus surgery versus surgery alone for large hepatocellular carcinoma (CSGO‐HBP‐005): Clinical Study Group of Osaka University, Hepato‐Biliary‐Pancreatic Group
di: Shogo Kobayashi, et al.
Pubblicazione: (2024)

Metabolic dysfunction‐associated fatty liver disease and risks of incident coronary artery disease and cerebrovascular disease: LIFE Study
di: Yurina Akeno, et al.
Pubblicazione: (2025)

Impact of the revised Japanese indication criteria for deceased donor liver transplantation on liver cirrhotic patients of Child–Pugh classification B with hepatocellular carcinoma
di: Akihiro Seki, et al.
Pubblicazione: (2025)

Comparison between Japan and Korea in liver transplantation: Focusing on a higher deceased donation rate in Korea
di: Soo Ryang Kim, et al.
Pubblicazione: (2025)

Colorectal adenoma detection rate using texture and color enhancement imaging versus white light imaging with chromoendoscopy: a propensity score matching study
di: Osamu Toyoshima, et al.
Pubblicazione: (2024)

Efficacy of steroid therapy for improving native liver survival after pediatric acute liver failure with immune activation
di: Hiroshi Oue, et al.
Pubblicazione: (2024)

Metabolic‐associated fatty liver disease and hepatocellular carcinoma: a prospective study of characteristics and response to therapy
di: NM Batt, et al.
Pubblicazione: (2024)

Effect of Rab18 on liver injury and lipid accumulation by regulating perilipin 2 and peroxisome proliferator‐activated receptor gamma in non‐alcoholic fatty liver disease
di: Lei Zhang, et al.
Pubblicazione: (2024)

Non‐alcoholic fatty liver disease: The importance of physical activity and nutrition education—A randomized controlled study
di: Diler Us Altay, et al.
Pubblicazione: (2024)

Validation study of age‐independent fibrosis score (Fibrosis‐3 index) in patients with metabolic dysfunction‐associated steatotic liver disease
di: Kazuhiro Nouso, et al.
Pubblicazione: (2024)

Hepatic Mac2‐BP expression depends on liver fibrosis and inflammation due to fat accumulation in patients with metabolic dysfunction‐associated steatotic liver disease
di: Haruki Uojima, et al.
Pubblicazione: (2024)

Letter to the editor: Non‐alcoholic fatty liver disease: The importance of physical activity and nutrition education—A randomized controlled study
di: S Khan, et al.
Pubblicazione: (2024)

Treatment of liver cirrhosis in the era of steatotic liver disease
di: Masahito Shimizu
Pubblicazione: (2024)

Validation of Japanese indication criteria for deceased donor liver transplantation for hepatocellular carcinoma: Analysis of US national registry data
di: Yuki Bekki, et al.
Pubblicazione: (2024)

Identification and Characterization of Three Novel Biomarkers for Mixed/Cholestatic Drug‐Induced Liver Injury
di: Kosuke Saito, et al.
Pubblicazione: (2025)

Upper gastrointestinal involvement of Behçet's disease in Japan: endoscopic findings and clinical features
di: Keita Murakami, et al.
Pubblicazione: (2024)